Knee Arthroscopy Prior to Total Knee Arthroplasty: Temporal Relationship to Surgical Complications

Oliver C. Sax; Sandeep S. Bains; Zhongming Chen; Christopher G. Salib; James Nace; Ronald E. Delanois

doi:10.1055/s-0042-1757595

The Journal of Knee Surgery, Inhaltsverzeichnis

J Knee Surg 2022; 35(14): 1504-1510
DOI: 10.1055/s-0042-1757595

Special Focus Section

Knee Arthroscopy Prior to Total Knee Arthroplasty: Temporal Relationship to Surgical Complications

Authors

Oliver C. Sax

¹Center for Joint Preservation and Replacement, LifeBridge Health, Rubin Institute for Advanced Orthopedics, Sinai Hospital of Baltimore, Baltimore, Maryland
Sandeep S. Bains

¹Center for Joint Preservation and Replacement, LifeBridge Health, Rubin Institute for Advanced Orthopedics, Sinai Hospital of Baltimore, Baltimore, Maryland
Zhongming Chen

¹Center for Joint Preservation and Replacement, LifeBridge Health, Rubin Institute for Advanced Orthopedics, Sinai Hospital of Baltimore, Baltimore, Maryland
Christopher G. Salib

¹Center for Joint Preservation and Replacement, LifeBridge Health, Rubin Institute for Advanced Orthopedics, Sinai Hospital of Baltimore, Baltimore, Maryland
James Nace

¹Center for Joint Preservation and Replacement, LifeBridge Health, Rubin Institute for Advanced Orthopedics, Sinai Hospital of Baltimore, Baltimore, Maryland
Ronald E. Delanois

¹Center for Joint Preservation and Replacement, LifeBridge Health, Rubin Institute for Advanced Orthopedics, Sinai Hospital of Baltimore, Baltimore, Maryland

Abstract

Mechanical knee symptoms secondary to knee osteoarthritis (OA) may warrant knee arthroscopy (KA). Degenerative changes may progress and require a subsequent total knee arthroplasty (TKA). Recent studies have evaluated the timing of KA prior to TKA, associated a narrow interval with increased post-TKA complications. However, an updated analysis is required. We compared surgical outcomes in recipients of KA prior to TKA as stratified by four, time-dependent cohorts (< 12, 12 to 16, 16 to 20, and 20 to 24 weeks prior to TKA). We specifically compared: 90-day (1) manipulations under anesthesia (MUAs); (2) septic revisions at 90 days, 1 year, and 2 years; as well as (3) how various independent risk factors influenced the manipulations or revisions. We queried a national database for patients undergoing TKA. Patients who underwent KA with the following intervals: < 12 (n = 1,023), 12 to 16 (n = 816), 16 to 20 (n = 1,957), and 20 to 24 weeks (1,727) prior to TKA were compared with those patients who did not have a history of KA (n = 5,000). Bivariate analyses were utilized to assess 90 days through 2 years surgical outcomes. Afterwards, multivariate regression models were utilized to assess for independent risk factors. The unadjusted analyses showed an increase in MUA through 2 years among all the KA recipients (p < 0.001). Septic revisions and surgical site infections at all time points were not associated with any of the four arthroscopy time intervals (p > 0.476). The adjusted analyses showed an increased risk for 90-day MUA among all TKA cohorts (p < 0.001). Risk for septic revisions did not reach significance. Delaying TKA by 24 weeks in KA recipients was not associated with a decreased risk in septic revisions. However, there was an apparent risk of MUA at 90 days for all KA cohorts suggesting that waiting after KA before TKA makes no difference in MUA rates. These results update existing literature, may serve as an adjunct to current practice guidelines, and can contribute to shared decision making in the preoperative setting.

Keywords

arthroscopy - TKA - knee - infection - revision

Volltext

Referenzen

References
1 American Academy of Orthopaedic Surgeons Management of Osteoarthritis of the Knee (Non-Arthroplasty) Evidence-Based Clinical Practice Guideline. 3rd ed. Rosemont, IL: American Academy of Orthopaedic Surgeons; 2021
2 Deshpande BR, Katz JN, Solomon DH. et al. Number of persons with symptomatic knee osteoarthritis in the US: impact of race and ethnicity, age, sex, and obesity. Arthritis Care Res (Hoboken) 2016; 68 (12) 1743-1750
3 Oganesyan R, Klemt C, Esposito J, Tirumala V, Xiong L, Kwon YM. Knee arthroscopy prior to revision TKA is associated with increased re-revision for stiffness. J Knee Surg 2022; 35 (11) 1223-1228
4 Barton SB, McLauchlan GJ, Canty SJ. The incidence and impact of arthroscopy in the year prior to total knee arthroplasty. Knee 2017; 24 (02) 396-401
5 Viste A, Abdel MP, Ollivier M, Mara KC, Krych AJ, Berry DJ. Prior knee arthroscopy does not influence long-term total knee arthroplasty outcomes and survivorship. J Arthroplasty 2017; 32 (12) 3626-3631
6 Gu A, Malahias MA, Cohen JS. et al. Prior knee arthroscopy is associated with increased risk of revision after total knee arthroplasty. J Arthroplasty 2020; 35 (01) 100-104
7 Gu A, Fassihi SC, Wessel LE. et al. Comparison of revision risk based on timing of knee arthroscopy prior to total knee arthroplasty. J Bone Joint Surg Am 2021; 103 (08) 660-667
8 Churchill JL, Sodhi N, Khlopas A. et al. Total knee arthroplasty fibrosis following arthroscopic intervention. Ann Transl Med 2017; 5 (Suppl. 03) S28
9 Werner BC, Burrus MT, Novicoff WM, Browne JA. Total knee arthroplasty within six months after knee arthroscopy is associated with increased postoperative complications. J Arthroplasty 2015; 30 (08) 1313-1316
10 Sloan M, Premkumar A, Sheth NP. Projected volume of primary total joint arthroplasty in the U.S., 2014 to 2030. J Bone Joint Surg Am 2018; 100 (17) 1455-1460
11 Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987; 40 (05) 373-383
12 Charlson M, Szatrowski TP, Peterson J, Gold J. Validation of a combined comorbidity index. J Clin Epidemiol 1994; 47 (11) 1245-1251
13 U.S. Department of Health & Human Services. Medicare Fee-for-Service Supplemental Improper Payment Data 2019; 2019: 1-80
14 Kim J, Nelson CL, Lotke PA. Stiffness after total knee arthroplasty. Prevalence of the complication and outcomes of revision. J Bone Joint Surg Am 2004; 86 (07) 1479-1484
15 Freeman TA, Parvizi J, Dela Valle CJ, Steinbeck MJ. Mast cells and hypoxia drive tissue metaplasia and heterotopic ossification in idiopathic arthrofibrosis after total knee arthroplasty. Fibrogenesis Tissue Repair 2010; 3: 17
16 Gollwitzer H, Burgkart R, Diehl P, Gradinger R, Bühren V. Therapie der arthrofibrose nach kniegelenkendoprothetik. Orthopade 2006; 35: 143-152
17 Kalson NS, Borthwick LA, Mann DA. et al. International consensus on the definition and classification of fibrosis of the knee joint. Bone Joint J 2016; 98-B (11) 1479-1488
18 Piedade SR, Pinaroli A, Servien E, Neyret P. Is previous knee arthroscopy related to worse results in primary total knee arthroplasty?. Knee Surg Sports Traumatol Arthrosc 2009; 17 (04) 328-333
19 Kurtz SM, Lau E, Watson H, Schmier JK, Parvizi J. Economic burden of periprosthetic joint infection in the United States. J Arthroplasty 2012; 27 (8, Suppl): 61-5.e1
20 Shohat N, Goswami K, Tan TL. et al. Frank Stinchfield Award: identifying who will fail following irrigation and debridement for prosthetic joint infection: a machine learning-based validated tool. Bone Joint J. 2020; 102-B (7_Supple_B): 11-19
21 Kurtz SM, Mont MA, Chen AF. et al. Intra-articular corticosteroid or hyaluronic acid injections are not associated with periprosthetic joint infection risk following total knee arthroplasty. J Knee Surg 2022; 35 (09) 983-996
22 Khan IA, Small I, Sutton RM. et al. Cumulative intraarticular injections are not a risk factor for periprosthetic joint infection following total knee arthroplasty. J Arthroplasty 2022; 37 (06) 1059-1063.e1
23 Richardson SS, Schairer WW, Sculco TP, Sculco PK. Comparison of infection risk with corticosteroid or hyaluronic acid injection prior to total knee arthroplasty. J Bone Joint Surg Am 2019; 101 (02) 112-118